Gold nanoparticles decorated polylactic acid-co-ethyl cellulose nanocapsules for 5-fluorouracil drug release Online publication date: Tue, 30-Sep-2014
by Kannaiyan Sathishkumar
International Journal of Nano and Biomaterials (IJNBM), Vol. 4, No. 1, 2012
Abstract: The present work describes the synthesis and characterisation of PLA-co-EC copolymer from lactic acid and ethyl cellulose by azeotropic dehydration, under reduced pressure, at 140°C for eight hours. The synthesised PLA-co-EC copolymer was used for controlled drug release systems with gold nanoparticles. Fluorouracil (5-Fu) containing PLA-co-EC nanocapsules were prepared in the presence and absence of gold nanoparticles via solvent evaporation method. The drug entrapped nanocapsules were characterised by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The average diameter of gold nanoparticles was found to be in the range of 18-20 nm and size of the nanocapsules was found to be in the range of 230-260 nm. The controlled drug release of anticancer drugs entrapped nanocapsules were carried out in 0.1M HCl and 0.1M phosphate buffer (pH-7.4). Results indicated that the drug release for gold nanoparticles incorporated PLA-co-EC nanocapsules was controlled and slow compare to Fu incorporated PLA-co-EC nanocapsules. This may be due the interaction between the gold nanoparticles and fluorouracil in PLA-co-EC nanocapsules.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nano and Biomaterials (IJNBM):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com